CLOs on the Move

InterVenn

www.intervenn.com

 
InterVenn Biosciences utilizes a proprietary high-throughput glycoproteomic interrogation platform using artificial intelligence and mass spectrometry for next-gen precision medicine. The company is working to find new solutions in ovarian, pancreatic, liver, prostate, and kidney cancer, together with applications from the Vista suite of solutions for treatment and monitoring, immune profiling, patient stratification, and disease progression.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.intervenn.com
  • 2 Tower Place 5th Floor
    South San Francisco, CA USA 94080
  • Phone: 888.706.1670

Executives

Name Title Contact Details
Stephana Patton
 Chief Legal and Compliance Officer Profile

Similar Companies

SQZ Biotech

SQZ Biotech is a unique cell therapy company, utilizing the proprietary CellSqueeze® platform to develop a new generation of cell therapies. SQZ currently focuses on the development of novel treatments that leverage targeted immune modulation to impact oncology and autoimmune diseases.

Cypress Bioscience

Cypress Bioscience, Inc. is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

AmCyte

AmCyte Inc. is a Santa Monica, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Integrity Laboratories

GABA Therapeutics,

A New Dawn for Central Nervous System Treatments GABA Therapeutics is developing GRX-917, an anxiety medication as effective as benzodiazepines like Xanax, but with minimal to no side effects. The drugs dual mechanism of action may also benefit ...